Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Unknown 2Terminated 1

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Gastrointestinal 3Breast 1

Conditions

Rectal Neoplasms 1Inflammation 1Feeding Behavior 1Digestive System Neoplasms 1Colorectal Neoplasms 1Cachexia 1

Interventions

Oxaliplatin 1439Fluorouracil 1319Capecitabine 1114Gemcitabine 1057Leucovorin 939Bevacizumab 847Irinotecan 830Cisplatin 676Radiotherapy 560Cetuximab 482pembrolizumab 435Paclitaxel 401Drug Therapy 358Nivolumab 350130-nm albumin-bound paclitaxel 329Docetaxel 290Sorafenib 288S 1 (combination) 279Folfox protocol 266Albumin-Bound Paclitaxel 263Surgical Procedures, Operative 258lenvatinib 222sintilimab 218tislelizumab 214durvalumab 212regorafenib 209Magnetic Resonance Spectroscopy 205apatinib 204Radiosurgery 204Neoadjuvant Therapy 190

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Body Height × Gastrointestinal × Clear all
NCT06018077 2023-08-30

Chemerin in Colorectal Cancer and Its Relationship With Diet Quality

Hacettepe University

Unknown
104 enrolled
Gastrointestinal

Feeding Behavior, Inflammation, Colorectal Neoplasms

NCT03172403 2022-08-25

MYOCAC

Centre Hospitalier Universitaire de Saint Etienne

Phase NA Terminated
3 enrolled
Gastrointestinal

Cachexia, Digestive System Neoplasms

NCT02280070 2014-10-31

RP II Study of SOX vs mFOLFOX6 in Patients With Resectable Rectal Cancer (KSCC1301).

Clinical Research Support Center Kyush

Phase 2 Unknown
110 enrolled
Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡